Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

HOME
Pharma Business
About us
- Media Kit
- Privacy Policy
Contact

Search for:

Tag: Zessly

Novartis’s Zessly approved in Europe

May 24, 2018 Off

Novartis’s Zessly approved in Europe

By Dino Mustafić

Novartis’s Sandoz has secured European Commission’s approval for biosimilar Zessly, the company said Thursday.

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

November 19, 2024 Off

Cosentyx meets the primary endpoints

June 15, 2015 Off

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

Proudly powered by WordPress | Theme: Envo Magazine